Accessibility Menu
InfuSystem logo

InfuSystem(NYSEMKT) INFU

Market Cap$184.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)+71%
5 Year-50%
1 Year+63%
1 Month-9%
$9.10
-0.98%
-0.09Today
After hours$9.12+$0.02 (+0.22%)
InfuSystem last closing stock price
MetricPriceDate
Last closeUSD 9.142026-07-31
InfuSystem stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.22%USD 9.122026-07-24
1 month-8.78%USD 10.022026-07-01
3 month-11.86%USD 10.372026-05-01
Year to date+1.9%USD 8.972025-12-31
1 year+63.21%USD 5.602025-07-31
3 year-9.59%USD 10.112023-08-01
5 year-49.92%USD 18.252021-07-30
Since inception+70.52%USD 5.362006-06-15

InfuSystem Financials at a Glance

Market Cap

$184.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$142.40M

Net Income (TTM)

$7.91M

EPS (TTM)

$0.38

P/E Ratio

24.27

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Price

$9.10

Volume

172,806.518

Open

$9.18

Previous Close

$9.14

Daily Range

$8.88 - $9.44

52-Week Range

$5.69 - $11.04

Estimated Earnings Date

Aug 4, 2026

INFU News

Foolcom-Featured.png

InfuSystem (INFU) Q2 EPS Jumps 300%

Motley Fool Markets TeamAug 5, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About InfuSystem

InfuSystem provides medical pumps and supplies to hospitals and clinics. Its products help deliver medication safely to patients needing cancer treatment or pain management. The company also repairs and maintains this equipment for healthcare providers.

Pumps, Kits, and More: What InfuSystem Sells

Disposable supply kits: Single-use items needed for each infusion treatment, used by clinics and hospitals (included in Patient Services).

Equipment sales, rentals, and leases: New and pre-owned pumps and other medical equipment for healthcare providers.

Biomedical services: Maintenance, repair, and recertification of medical equipment for clinics, home care, and nursing facilities.

IT-based services: Software tools for tracking, managing, and reporting on pump usage and patient care.

Growth Moves: InfuSystem’s Expansion Playbook

Acquired Apollo Medical Supply in May 2025 to expand wound care services.

Formed a wound care partnership with Sanara MedTech through SI Healthcare Technologies, LLC.

Added new IT-based service platforms and upgraded business applications in 2024 and 2025.

Expanded pump service centers to seven locations across the U.S. and Canada by 2025.

Launched a $20 million share repurchase program through June 2026.

What Makes InfuSystem Stand Out

InfuSystem’s broad network of payer contracts and pump fleet supports fast delivery to healthcare providers. Its field-based technicians and multiple service centers enable responsive equipment repair. Accredited operations and IT investments help maintain reliability and compliance.

Five Things You Need to Know

Q3 2025 revenue was $36 million, up 3.3% from $35 million in Q3 2024.

Net cash from operations was $8.8 million for the first half of 2025, up from $2.7 million.

Bottom Line

InfuSystem has grown by expanding services, acquiring new businesses, and investing in technology. The company’s focus on medical equipment and support services positions it as a key supplier to North American healthcare providers.

AI Generated • Apr 16, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

473

CEO

Carrie A. Lachance, MBA

Website

www.infusystem.com

Headquarters

Rochester Hills, MI 48309, US

INFU Financials

Key Financial Metrics (TTM)

Gross Margin

56.75%

Operating Margin

9.05%

Net Income Margin

5.56%

Return on Equity

14.00%

Return on Capital

19.62%

Return on Assets

8.02%

Earnings Yield

4.12%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$184.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

20.18M

Volume

172.81K

Avg. Volume

223.63K

Financials (TTM)

Gross Profit

$80.81M

Operating Income

$12.89M

EBITDA

$25.86M

Operating Cash Flow

$23.60M

Capital Expenditure

-$4.32M

Free Cash Flow

$19.28M

Cash & ST Invst.

$2.11M

Total Debt

$22.77M

InfuSystem Performance Analysis

InfuSystem annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 109,914,0007.4%
20232023-12-31USD 125,785,00014.4%
20242024-12-31USD 134,861,0007.2%
20252025-12-31USD 143,436,0006.4%
InfuSystem sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-303.7%
Q32025-09-301.3%
Q42025-12-31-0.7%
Q12026-03-31-7.0%
InfuSystem annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.00-98.8%
20232023-12-31USD 0.044937.5%
20242024-12-31USD 0.11168.0%
20252025-12-31USD 0.31190.8%
InfuSystem sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-301300.0%
Q32025-09-30-8.3%
Q42025-12-31-12.2%
Q12026-03-31-49.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$33.68M

-3.0%

Gross Profit

$19.68M

+2.7%

Gross Margin

58.43%

N/A

Market Cap

$184.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$367.45K

N/A

Employees

502

N/A

Net Income

$1.02M

+480.9%

EBITDA

$4.42M

+13.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$2.11M

+39.8%

Total Debt

$22.77M

-31.4%

Accounts Receivable

$23.98M

+0.4%

Inventory

$5.83M

-4.3%

Long Term Debt

$22.77M

-31.4%

Short Term Debt

$0.00

N/A

Return on Assets

8.02%

N/A

Return on Invested Capital

15.82%

N/A

Free Cash Flow

-$867.00K

-152.6%

Operating Cash Flow

$970.00K

-45.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KRMDKORU Medical Systems, Inc.
$4.11+0.00%
UTMDUtah Medical Products, Inc.
$70.52+1.37%
IVAInventiva S.A.
$4.48-3.03%
OBIOOrchestra BioMed Holdings, Inc.
$3.98-0.25%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.31+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.73-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$64.62+0.02%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$23.67-0.12%

Questions About INFU

What is the current price of InfuSystem?

InfuSystem is trading at $9.14 per share.

What is the 52-week range for InfuSystem?

Over the past 52 weeks, InfuSystem has traded between $5.69 and $11.04.

How much debt does InfuSystem have?

As of the most recent reporting period, InfuSystem reported total debt of $22.77M.

How much cash does InfuSystem have on hand?

InfuSystem reported $2.11M in cash and cash equivalents in its most recent financial results.

What is InfuSystem’s dividend yield?

InfuSystem does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services